Recilisib (sodium)

• UNSPSC Description:

  Recilisib sodium (ON 01210) is a radioprotectant, which can activate AKT, PI3K activities in cells[1].

• Target Antigen:

  Akt; PI3K

• Type:

  Reference compound

• Related Pathways:

  PI3K/Akt/mTOR

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/recilisib-sodium.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C1=CC=C(C=C1)/C=C/S(=O)(CC2=CC=C(C=C2)Cl)=O)O[Na]

• Molecular Weight:

  358.77

• References & Citations:

  [1]Kang AD, et al. ON01210.Na (Ex-RAD) mitigates radiation damage through activation of the AKT pathway. PLoS One. 2013;8(3):e58355.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 1

• CAS Number:

  922139-31-9